Effect of oestrogen receptor status and time on the intra-tumoural accumulation of tamoxifen and N-desmethyltamoxifen following short-term therapy in human primary breast cancer-Reference-Cited by-同舟云学术

Effect of oestrogen receptor status and time on the intra-tumoural accumulation of tamoxifen and N-desmethyltamoxifen following short-term therapy in human primary breast cancer

Published:1993 Issue:3 Volume:28 Page:241-250
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Tr

Author:

Johnston S. R. D.,Haynes B. P.,Sacks N. P. M.,McKinna J. A.,Griggs L. J.,Jarman M.,Baum M.,Smith I. E.,Dowsett M.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/BF00666585.pdf

Reference24 articles.

1. McGuire WL: Hormone receptors: their role in predicting prognosis and response to endocrine therapy. Semin Oncol 5: 428?433, 1978

2. Jordan VC: Metabolites of tamoxifen in animals and man: identification, pharmacology and significance. Breast Cancer Res Treat 3: 123?138, 1982

3. Daniel P, Gaskell SJ, Bishop H, Campbell C, Robertson RI: Determination of tamoxifen and biologically active metabolites in human breast tumours and plasma. Eur J Cancer Clin Oncol 17: 1183?1189, 1981

4. Lien EA, Ueland PM, Solheim E, Kvinnsland S: Determination of tamoxifen and four metabolites in serum by low-dispersion liquid chromatography. Clin Chem 33: 1608?1614, 1987

5. Fabian C, Titzer L, Sternson L: Comparative binding affinities of tamoxifen, 4-hydroxytamoxifen, and desmethyltamoxifen for estrogen receptors isolated from human breast carcinoma; correlation with blood levels in patients with metastatic breast cancer. Biopharm Drug Dispos 2: 381?390, 1981

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tamoxifen regulation of sphingolipid metabolism—Therapeutic implications;Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids;2015-09

2. Redox biology in normal cells and cancer: Restoring function of the redox/Fyn/c-Cbl pathway in cancer cells offers new approaches to cancer treatment;Free Radical Biology and Medicine;2015-02

3. Inhibition of redox/Fyn/c‐Cbl pathway function by Cdc42 controls tumour initiation capacity and tamoxifen sensitivity in basal‐like breast cancer cells;EMBO Molecular Medicine;2013-04-22

4. Physiologically based pharmacokinetic modeling of tamoxifen and its metabolites in women of different CYP2D6 phenotypes provides new insight into the tamoxifen mass balance;Frontiers in Pharmacology;2012

5. Breast Cancer Chemoprevention: Old and New Approaches;Journal of Biomedicine and Biotechnology;2012